nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRFAM7A—corpus luteum—uterine cancer	0.0891	0.319	CbGeAlD
Varenicline—CHRNA7—corpus luteum—uterine cancer	0.0719	0.257	CbGeAlD
Varenicline—CHRNB2—myometrium—uterine cancer	0.0125	0.0447	CbGeAlD
Varenicline—CHRNB2—uterine cervix—uterine cancer	0.00972	0.0348	CbGeAlD
Varenicline—CHRNB2—smooth muscle tissue—uterine cancer	0.00944	0.0338	CbGeAlD
Varenicline—CHRNB2—decidua—uterine cancer	0.00926	0.0331	CbGeAlD
Varenicline—CHRNB2—endometrium—uterine cancer	0.00879	0.0314	CbGeAlD
Varenicline—CHRNB2—mammalian vulva—uterine cancer	0.0085	0.0304	CbGeAlD
Varenicline—CHRNB2—uterus—uterine cancer	0.0081	0.029	CbGeAlD
Varenicline—CHRNB2—female gonad—uterine cancer	0.00662	0.0237	CbGeAlD
Varenicline—CHRNB2—vagina—uterine cancer	0.00658	0.0236	CbGeAlD
Varenicline—CHRNA7—renal system—uterine cancer	0.00576	0.0206	CbGeAlD
Varenicline—CHRFAM7A—female reproductive system—uterine cancer	0.00571	0.0204	CbGeAlD
Varenicline—CHRFAM7A—female gonad—uterine cancer	0.0052	0.0186	CbGeAlD
Varenicline—CHRNA7—uterus—uterine cancer	0.00513	0.0184	CbGeAlD
Varenicline—CHRNA7—female reproductive system—uterine cancer	0.00461	0.0165	CbGeAlD
Varenicline—CHRNB2—lymph node—uterine cancer	0.00426	0.0152	CbGeAlD
Varenicline—CHRNA7—female gonad—uterine cancer	0.0042	0.015	CbGeAlD
Varenicline—CHRNA3—lymph node—uterine cancer	0.00413	0.0148	CbGeAlD
Varenicline—Lethargy—Doxorubicin—uterine cancer	0.000517	0.000717	CcSEcCtD
Varenicline—Cough—Etoposide—uterine cancer	0.000513	0.000712	CcSEcCtD
Varenicline—Convulsion—Etoposide—uterine cancer	0.000509	0.000707	CcSEcCtD
Varenicline—Hypertension—Etoposide—uterine cancer	0.000507	0.000704	CcSEcCtD
Varenicline—Osteoarthritis—Doxorubicin—uterine cancer	0.000506	0.000703	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000506	0.000703	CcSEcCtD
Varenicline—Liver function test abnormal—Epirubicin—uterine cancer	0.000505	0.000701	CcSEcCtD
Varenicline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000505	0.000701	CcSEcCtD
Varenicline—Dry skin—Epirubicin—uterine cancer	0.000501	0.000696	CcSEcCtD
Varenicline—Chest pain—Etoposide—uterine cancer	0.0005	0.000695	CcSEcCtD
Varenicline—Abdominal pain upper—Epirubicin—uterine cancer	0.0005	0.000694	CcSEcCtD
Varenicline—Affect lability—Doxorubicin—uterine cancer	0.000498	0.000692	CcSEcCtD
Varenicline—Migraine—Doxorubicin—uterine cancer	0.000498	0.000692	CcSEcCtD
Varenicline—Hypokalaemia—Epirubicin—uterine cancer	0.000498	0.000691	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000497	0.00069	CcSEcCtD
Varenicline—Discomfort—Etoposide—uterine cancer	0.000494	0.000686	CcSEcCtD
Varenicline—Breast disorder—Epirubicin—uterine cancer	0.000494	0.000686	CcSEcCtD
Varenicline—Nasopharyngitis—Epirubicin—uterine cancer	0.000489	0.000679	CcSEcCtD
Varenicline—Hypersensitivity—Dactinomycin—uterine cancer	0.000488	0.000678	CcSEcCtD
Varenicline—Gastritis—Epirubicin—uterine cancer	0.000484	0.000672	CcSEcCtD
Varenicline—Mood swings—Doxorubicin—uterine cancer	0.00048	0.000666	CcSEcCtD
Varenicline—Infection—Etoposide—uterine cancer	0.000477	0.000661	CcSEcCtD
Varenicline—Abdominal distension—Epirubicin—uterine cancer	0.000476	0.000661	CcSEcCtD
Varenicline—Asthenia—Dactinomycin—uterine cancer	0.000476	0.00066	CcSEcCtD
Varenicline—Asthma—Epirubicin—uterine cancer	0.000473	0.000656	CcSEcCtD
Varenicline—Dysphagia—Epirubicin—uterine cancer	0.000473	0.000656	CcSEcCtD
Varenicline—Thrombocytopenia—Etoposide—uterine cancer	0.00047	0.000652	CcSEcCtD
Varenicline—Tachycardia—Etoposide—uterine cancer	0.000468	0.00065	CcSEcCtD
Varenicline—Liver function test abnormal—Doxorubicin—uterine cancer	0.000467	0.000649	CcSEcCtD
Varenicline—Skin disorder—Etoposide—uterine cancer	0.000466	0.000647	CcSEcCtD
Varenicline—Dry skin—Doxorubicin—uterine cancer	0.000464	0.000644	CcSEcCtD
Varenicline—Hyperhidrosis—Etoposide—uterine cancer	0.000464	0.000644	CcSEcCtD
Varenicline—Abdominal pain upper—Doxorubicin—uterine cancer	0.000462	0.000642	CcSEcCtD
Varenicline—Hypokalaemia—Doxorubicin—uterine cancer	0.000461	0.000639	CcSEcCtD
Varenicline—Angina pectoris—Epirubicin—uterine cancer	0.000461	0.000639	CcSEcCtD
Varenicline—Breast disorder—Doxorubicin—uterine cancer	0.000457	0.000635	CcSEcCtD
Varenicline—Anorexia—Etoposide—uterine cancer	0.000457	0.000635	CcSEcCtD
Varenicline—Bronchitis—Epirubicin—uterine cancer	0.000455	0.000631	CcSEcCtD
Varenicline—Diarrhoea—Dactinomycin—uterine cancer	0.000454	0.000629	CcSEcCtD
Varenicline—Nasopharyngitis—Doxorubicin—uterine cancer	0.000453	0.000628	CcSEcCtD
Varenicline—Hypotension—Etoposide—uterine cancer	0.000448	0.000622	CcSEcCtD
Varenicline—Gastritis—Doxorubicin—uterine cancer	0.000448	0.000622	CcSEcCtD
Varenicline—Abdominal distension—Doxorubicin—uterine cancer	0.00044	0.000611	CcSEcCtD
Varenicline—Asthma—Doxorubicin—uterine cancer	0.000438	0.000607	CcSEcCtD
Varenicline—Dysphagia—Doxorubicin—uterine cancer	0.000438	0.000607	CcSEcCtD
Varenicline—Pollakiuria—Epirubicin—uterine cancer	0.000437	0.000606	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—uterine cancer	0.000432	0.000599	CcSEcCtD
Varenicline—Weight increased—Epirubicin—uterine cancer	0.00043	0.000597	CcSEcCtD
Varenicline—Dyspnoea—Etoposide—uterine cancer	0.000428	0.000594	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—uterine cancer	0.000427	0.000592	CcSEcCtD
Varenicline—Somnolence—Etoposide—uterine cancer	0.000426	0.000592	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—uterine cancer	0.000426	0.000592	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—uterine cancer	0.000422	0.000585	CcSEcCtD
Varenicline—Infestation—Epirubicin—uterine cancer	0.000422	0.000585	CcSEcCtD
Varenicline—Vomiting—Dactinomycin—uterine cancer	0.000421	0.000585	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—uterine cancer	0.000421	0.000584	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000418	0.00058	CcSEcCtD
Varenicline—Rash—Dactinomycin—uterine cancer	0.000418	0.00058	CcSEcCtD
Varenicline—Decreased appetite—Etoposide—uterine cancer	0.000417	0.000579	CcSEcCtD
Varenicline—Gastrointestinal disorder—Etoposide—uterine cancer	0.000414	0.000575	CcSEcCtD
Varenicline—Fatigue—Etoposide—uterine cancer	0.000414	0.000574	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—uterine cancer	0.000411	0.00057	CcSEcCtD
Varenicline—Constipation—Etoposide—uterine cancer	0.00041	0.000569	CcSEcCtD
Varenicline—Pain—Etoposide—uterine cancer	0.00041	0.000569	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—uterine cancer	0.00041	0.000569	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—uterine cancer	0.000404	0.000561	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000399	0.000554	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—uterine cancer	0.000399	0.000553	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—uterine cancer	0.000398	0.000553	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—uterine cancer	0.000398	0.000552	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—uterine cancer	0.000396	0.000549	CcSEcCtD
Varenicline—Feeling abnormal—Etoposide—uterine cancer	0.000395	0.000549	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—uterine cancer	0.000395	0.000548	CcSEcCtD
Varenicline—Nausea—Dactinomycin—uterine cancer	0.000394	0.000546	CcSEcCtD
Varenicline—Gastrointestinal pain—Etoposide—uterine cancer	0.000392	0.000544	CcSEcCtD
Varenicline—Infestation—Doxorubicin—uterine cancer	0.00039	0.000541	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—uterine cancer	0.00039	0.000541	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000387	0.000537	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—uterine cancer	0.000385	0.000535	CcSEcCtD
Varenicline—Urticaria—Etoposide—uterine cancer	0.000381	0.000529	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—uterine cancer	0.00038	0.000528	CcSEcCtD
Varenicline—Abdominal pain—Etoposide—uterine cancer	0.000379	0.000526	CcSEcCtD
Varenicline—Body temperature increased—Etoposide—uterine cancer	0.000379	0.000526	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—uterine cancer	0.000379	0.000526	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—uterine cancer	0.000377	0.000523	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—uterine cancer	0.000374	0.000519	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—uterine cancer	0.000373	0.000518	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—uterine cancer	0.000372	0.000516	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—uterine cancer	0.000371	0.000515	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000369	0.000512	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—uterine cancer	0.000368	0.000511	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—uterine cancer	0.000366	0.000508	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—uterine cancer	0.000365	0.000506	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—uterine cancer	0.000358	0.000497	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—uterine cancer	0.000357	0.000495	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—uterine cancer	0.000354	0.000491	CcSEcCtD
Varenicline—Hypersensitivity—Etoposide—uterine cancer	0.000353	0.000491	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—uterine cancer	0.000353	0.00049	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—uterine cancer	0.000351	0.000488	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—uterine cancer	0.000348	0.000484	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—uterine cancer	0.000346	0.00048	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—uterine cancer	0.000345	0.000479	CcSEcCtD
Varenicline—Asthenia—Etoposide—uterine cancer	0.000344	0.000478	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—uterine cancer	0.000344	0.000478	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—uterine cancer	0.000343	0.000477	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—uterine cancer	0.000343	0.000476	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—uterine cancer	0.000342	0.000474	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—uterine cancer	0.000341	0.000473	CcSEcCtD
Varenicline—Chills—Epirubicin—uterine cancer	0.00034	0.000471	CcSEcCtD
Varenicline—Pruritus—Etoposide—uterine cancer	0.000339	0.000471	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—uterine cancer	0.000338	0.000469	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—uterine cancer	0.000337	0.000468	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—uterine cancer	0.000332	0.00046	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—uterine cancer	0.000331	0.00046	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—uterine cancer	0.000329	0.000457	CcSEcCtD
Varenicline—Erythema—Epirubicin—uterine cancer	0.000329	0.000457	CcSEcCtD
Varenicline—Diarrhoea—Etoposide—uterine cancer	0.000328	0.000456	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—uterine cancer	0.000327	0.000454	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—uterine cancer	0.000327	0.000453	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—uterine cancer	0.000325	0.000451	CcSEcCtD
Varenicline—Flatulence—Epirubicin—uterine cancer	0.000325	0.000451	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—uterine cancer	0.000323	0.000448	CcSEcCtD
Varenicline—Back pain—Epirubicin—uterine cancer	0.000319	0.000442	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—uterine cancer	0.000318	0.000441	CcSEcCtD
Varenicline—Dizziness—Etoposide—uterine cancer	0.000317	0.00044	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—uterine cancer	0.000317	0.00044	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—uterine cancer	0.000316	0.000439	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—uterine cancer	0.000316	0.000438	CcSEcCtD
Varenicline—Chills—Doxorubicin—uterine cancer	0.000314	0.000436	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—uterine cancer	0.000313	0.000434	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—uterine cancer	0.000311	0.000431	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—uterine cancer	0.000307	0.000426	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—uterine cancer	0.000306	0.000424	CcSEcCtD
Varenicline—Vomiting—Etoposide—uterine cancer	0.000305	0.000423	CcSEcCtD
Varenicline—Erythema—Doxorubicin—uterine cancer	0.000305	0.000423	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—uterine cancer	0.000305	0.000423	CcSEcCtD
Varenicline—Anaemia—Epirubicin—uterine cancer	0.000305	0.000423	CcSEcCtD
Varenicline—Agitation—Epirubicin—uterine cancer	0.000303	0.00042	CcSEcCtD
Varenicline—Rash—Etoposide—uterine cancer	0.000302	0.00042	CcSEcCtD
Varenicline—Dermatitis—Etoposide—uterine cancer	0.000302	0.000419	CcSEcCtD
Varenicline—Headache—Etoposide—uterine cancer	0.000301	0.000417	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—uterine cancer	0.0003	0.000417	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—uterine cancer	0.000299	0.000414	CcSEcCtD
Varenicline—Malaise—Epirubicin—uterine cancer	0.000297	0.000412	CcSEcCtD
Varenicline—Vertigo—Epirubicin—uterine cancer	0.000296	0.000411	CcSEcCtD
Varenicline—Syncope—Epirubicin—uterine cancer	0.000295	0.00041	CcSEcCtD
Varenicline—Back pain—Doxorubicin—uterine cancer	0.000295	0.000409	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—uterine cancer	0.000293	0.000407	CcSEcCtD
Varenicline—Palpitations—Epirubicin—uterine cancer	0.000291	0.000404	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—uterine cancer	0.00029	0.000402	CcSEcCtD
Varenicline—Cough—Epirubicin—uterine cancer	0.000288	0.000399	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—uterine cancer	0.000287	0.000399	CcSEcCtD
Varenicline—Convulsion—Epirubicin—uterine cancer	0.000285	0.000396	CcSEcCtD
Varenicline—Nausea—Etoposide—uterine cancer	0.000285	0.000395	CcSEcCtD
Varenicline—Hypertension—Epirubicin—uterine cancer	0.000284	0.000395	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000283	0.000393	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—uterine cancer	0.000282	0.000391	CcSEcCtD
Varenicline—Chest pain—Epirubicin—uterine cancer	0.000281	0.000389	CcSEcCtD
Varenicline—Myalgia—Epirubicin—uterine cancer	0.000281	0.000389	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—uterine cancer	0.000281	0.000389	CcSEcCtD
Varenicline—Agitation—Doxorubicin—uterine cancer	0.00028	0.000389	CcSEcCtD
Varenicline—Anxiety—Epirubicin—uterine cancer	0.00028	0.000388	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000279	0.000387	CcSEcCtD
Varenicline—Discomfort—Epirubicin—uterine cancer	0.000277	0.000385	CcSEcCtD
Varenicline—Malaise—Doxorubicin—uterine cancer	0.000275	0.000382	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—uterine cancer	0.000274	0.000381	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—uterine cancer	0.000274	0.00038	CcSEcCtD
Varenicline—Syncope—Doxorubicin—uterine cancer	0.000273	0.000379	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—uterine cancer	0.000269	0.000374	CcSEcCtD
Varenicline—Oedema—Epirubicin—uterine cancer	0.000269	0.000373	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—uterine cancer	0.000268	0.000372	CcSEcCtD
Varenicline—Infection—Epirubicin—uterine cancer	0.000267	0.000371	CcSEcCtD
Varenicline—Cough—Doxorubicin—uterine cancer	0.000266	0.000369	CcSEcCtD
Varenicline—Shock—Epirubicin—uterine cancer	0.000265	0.000367	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—uterine cancer	0.000264	0.000367	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—uterine cancer	0.000264	0.000366	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—uterine cancer	0.000263	0.000365	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—uterine cancer	0.000263	0.000365	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—uterine cancer	0.000262	0.000364	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—uterine cancer	0.000261	0.000363	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—uterine cancer	0.00026	0.000361	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—uterine cancer	0.00026	0.00036	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—uterine cancer	0.00026	0.00036	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—uterine cancer	0.00026	0.00036	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—uterine cancer	0.000259	0.000359	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000258	0.000358	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—uterine cancer	0.000256	0.000356	CcSEcCtD
Varenicline—Anorexia—Epirubicin—uterine cancer	0.000256	0.000356	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—uterine cancer	0.000254	0.000352	CcSEcCtD
Varenicline—Hypotension—Epirubicin—uterine cancer	0.000251	0.000349	CcSEcCtD
Varenicline—Oedema—Doxorubicin—uterine cancer	0.000249	0.000345	CcSEcCtD
Varenicline—Infection—Doxorubicin—uterine cancer	0.000247	0.000343	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000245	0.00034	CcSEcCtD
Varenicline—Shock—Doxorubicin—uterine cancer	0.000245	0.00034	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—uterine cancer	0.000244	0.000339	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000244	0.000338	CcSEcCtD
Varenicline—Insomnia—Epirubicin—uterine cancer	0.000243	0.000338	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—uterine cancer	0.000243	0.000337	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—uterine cancer	0.000242	0.000335	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000241	0.000334	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—uterine cancer	0.00024	0.000333	CcSEcCtD
Varenicline—Somnolence—Epirubicin—uterine cancer	0.000239	0.000332	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—uterine cancer	0.000237	0.000329	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—uterine cancer	0.000237	0.000329	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—uterine cancer	0.000234	0.000324	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—uterine cancer	0.000232	0.000323	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000232	0.000322	CcSEcCtD
Varenicline—Fatigue—Epirubicin—uterine cancer	0.000232	0.000322	CcSEcCtD
Varenicline—Pain—Epirubicin—uterine cancer	0.00023	0.000319	CcSEcCtD
Varenicline—Constipation—Epirubicin—uterine cancer	0.00023	0.000319	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000227	0.000315	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—uterine cancer	0.000225	0.000312	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—uterine cancer	0.000222	0.000308	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—uterine cancer	0.000222	0.000308	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—uterine cancer	0.000221	0.000307	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—uterine cancer	0.00022	0.000305	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—uterine cancer	0.000219	0.000304	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—uterine cancer	0.000216	0.0003	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000215	0.000298	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—uterine cancer	0.000215	0.000298	CcSEcCtD
Varenicline—Urticaria—Epirubicin—uterine cancer	0.000214	0.000296	CcSEcCtD
Varenicline—Pain—Doxorubicin—uterine cancer	0.000213	0.000295	CcSEcCtD
Varenicline—Constipation—Doxorubicin—uterine cancer	0.000213	0.000295	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—uterine cancer	0.000213	0.000295	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—uterine cancer	0.000213	0.000295	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—uterine cancer	0.000205	0.000285	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000203	0.000282	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—uterine cancer	0.000198	0.000275	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—uterine cancer	0.000198	0.000274	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—uterine cancer	0.000197	0.000273	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—uterine cancer	0.000197	0.000273	CcSEcCtD
Varenicline—Asthenia—Epirubicin—uterine cancer	0.000193	0.000268	CcSEcCtD
Varenicline—Pruritus—Epirubicin—uterine cancer	0.00019	0.000264	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—uterine cancer	0.000184	0.000255	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—uterine cancer	0.000183	0.000254	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—uterine cancer	0.000179	0.000248	CcSEcCtD
Varenicline—Dizziness—Epirubicin—uterine cancer	0.000178	0.000247	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—uterine cancer	0.000176	0.000244	CcSEcCtD
Varenicline—Vomiting—Epirubicin—uterine cancer	0.000171	0.000237	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—uterine cancer	0.00017	0.000236	CcSEcCtD
Varenicline—Rash—Epirubicin—uterine cancer	0.00017	0.000235	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—uterine cancer	0.000169	0.000235	CcSEcCtD
Varenicline—Headache—Epirubicin—uterine cancer	0.000168	0.000234	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—uterine cancer	0.000165	0.000228	CcSEcCtD
Varenicline—Nausea—Epirubicin—uterine cancer	0.00016	0.000222	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—uterine cancer	0.000158	0.00022	CcSEcCtD
Varenicline—Rash—Doxorubicin—uterine cancer	0.000157	0.000218	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—uterine cancer	0.000157	0.000218	CcSEcCtD
Varenicline—Headache—Doxorubicin—uterine cancer	0.000156	0.000216	CcSEcCtD
Varenicline—Nausea—Doxorubicin—uterine cancer	0.000148	0.000205	CcSEcCtD
